Eslie Dennis

1.3k total citations
18 papers, 1000 citations indexed

About

Eslie Dennis is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Eslie Dennis has authored 18 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Eslie Dennis's work include HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Gastrointestinal motility and disorders (4 papers). Eslie Dennis is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Gastrointestinal motility and disorders (4 papers). Eslie Dennis collaborates with scholars based in United States, Switzerland and Japan. Eslie Dennis's co-authors include Victoria Barghout, A. P. S. Hungin, Lin Chang, G. Richard Locke, Michael D. Crowell, Kevin W. Olden, Brian E. Lacy, Nicholas J. Talley, Hiroaki Nitta and Landon J. Inge and has published in prestigious journals such as Cancer Research, The American Journal of Gastroenterology and American Journal of Kidney Diseases.

In The Last Decade

Eslie Dennis

18 papers receiving 960 citations

Peers

Eslie Dennis
Kyu Joo Park South Korea
Andrzej Matyja Poland
Emanuela Miceli Italy
Hong Yang China
John Birk United States
L Demling Germany
Tarun Gupta India
Jason Hart Canada
Michelle Buresi Canada
Helen Wang United States
Kyu Joo Park South Korea
Eslie Dennis
Citations per year, relative to Eslie Dennis Eslie Dennis (= 1×) peers Kyu Joo Park

Countries citing papers authored by Eslie Dennis

Since Specialization
Citations

This map shows the geographic impact of Eslie Dennis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eslie Dennis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eslie Dennis more than expected).

Fields of papers citing papers by Eslie Dennis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eslie Dennis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eslie Dennis. The network helps show where Eslie Dennis may publish in the future.

Co-authorship network of co-authors of Eslie Dennis

This figure shows the co-authorship network connecting the top 25 collaborators of Eslie Dennis. A scholar is included among the top collaborators of Eslie Dennis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eslie Dennis. Eslie Dennis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Phillips, Gail D. Lewis, et al.. (2021). Activity of trastuzumab emtansine (T-DM1) in 3D cell culture. Breast Cancer Research and Treatment. 188(1). 65–75. 11 indexed citations
3.
Inge, Landon J. & Eslie Dennis. (2020). Development and applications of computer image analysis algorithms for scoring of PD-L1 immunohistochemistry. Immuno-Oncology Technology. 6. 2–8. 32 indexed citations
4.
5.
Masuda, Shinobu, et al.. (2019). Intratumoral Estrogen Receptor Heterogeneity of Expression in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer as Evaluated by a Brightfield Multiplex Assay. Journal of Histochemistry & Cytochemistry. 67(8). 563–574. 4 indexed citations
6.
Vennapusa, Bharathi, Brian M. Baker, Marcin Kowanetz, et al.. (2018). Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab. Applied immunohistochemistry & molecular morphology. 27(2). 92–100. 136 indexed citations
7.
Nitta, Hiroaki, Brian Kelly, Craig Allred, et al.. (2016). The assessment of HER2 status in breast cancer: the past, the present, and the future. Pathology International. 66(6). 313–324. 67 indexed citations
8.
Kurozumi, Sasagu, Masafumi Kurosumi, Hiroshi Matsumoto, et al.. (2016). HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients. Breast Cancer Research and Treatment. 158(1). 99–111. 32 indexed citations
9.
Banks, Peter A., Richard W. Brown, John Carpenter, et al.. (2016). A Proposed Set of Metrics to Reduce Patient Safety Risk From Within the Anatomic Pathology Laboratory. Laboratory Medicine. 48(2). 195–201. 7 indexed citations
10.
Dennis, Eslie, Peter M. Banks, Isabell R. Loftin, et al.. (2016). Validation of an electronic program for pathologist training in the interpretation of a complex companion diagnostic immunohistochemical assay. Human Pathology. 56. 194–203. 4 indexed citations
11.
Perrone, Ronald D., Jon Neville, Arlene B. Chapman, et al.. (2015). Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC). American Journal of Kidney Diseases. 66(4). 583–590. 19 indexed citations
12.
Nishida, Yasunori, Takeshi Kuwata, Hiroaki Nitta, et al.. (2014). A novel gene–protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity. Gastric Cancer. 18(3). 458–466. 34 indexed citations
13.
Dennis, Eslie, et al.. (2013). Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium. Drug Development Research. 74(2). 112–126. 5 indexed citations
14.
Hungin, A. P. S., Lin Chang, G. Richard Locke, Eslie Dennis, & Victoria Barghout. (2005). Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Alimentary Pharmacology & Therapeutics. 21(11). 1365–1375. 391 indexed citations
15.
Meerveld, B. Greenwood-Van, Kalina Venkova, Gareth A. Hicks, Eslie Dennis, & Michael D. Crowell. (2005). Activation of peripheral 5‐HT4receptors attenuates colonic sensitivity to intraluminal distension. Neurogastroenterology & Motility. 18(1). 76–86. 50 indexed citations
16.
Schiller, Lawrence R., et al.. (2004). PRIMARY CARE PHYSICIANS CONSIDER CONSTIPATION AS A SEVERE AND BOTHERSOME MEDICAL CONDITION THAT NEGATIVELY IMPACTS PATIENTSʼ LIVES. The American Journal of Gastroenterology. 99. S234–S235. 3 indexed citations
17.
Schiller, Lawrence R., et al.. (2004). AN INTERNET-BASED SURVEY OF THE PREVALENCE AND SYMPTOM SPECTRUM OF CHRONIC CONSTIPATION. The American Journal of Gastroenterology. 99. S234–S234. 8 indexed citations
18.
Talley, Nicholas J., et al.. (2003). Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. The American Journal of Gastroenterology. 98(11). 2454–2459. 193 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyu Joo Park Breakdown of academic impact, for papers by Andrzej Matyja Breakdown of academic impact, for papers by Emanuela Miceli Breakdown of academic impact, for papers by Hong Yang Breakdown of academic impact, for papers by John Birk Breakdown of academic impact, for papers by L Demling Breakdown of academic impact, for papers by Tarun Gupta Breakdown of academic impact, for papers by Jason Hart Breakdown of academic impact, for papers by Michelle Buresi Breakdown of academic impact, for papers by Helen Wang
Rankless by CCL
2026